Another in vitro study reported that in glioma-initiating cells, the repression of PI3K/AKT/mechanistic target of rapamycin (mTOR) signaling and sonic hedgehog signaling markedly reduced cell survival, renewal capacity and tumorigenic potential (Nanta et al. 2019). This evidence concerns the gene MTOR and central nervous system cancer.